Scolr Pharma, Inc.
SEC CIK 934936 · SCLR · last insider filing 2012-02-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Turner Stephen | Director · V.P., Chief Technical Officer | filed 2006 - 2012 |
| Taglich Michael N | Director | filed 2006 - 2011 |
| Lucas Herbert L JR | Director | filed 2006 - 2011 |
| Johnson Carl J | Director | filed 2010 - 2011 |
| Pines Wayne L | Director | filed 2006 - 2011 |
| Jeffrey Reich | Director | filed 2007 - 2011 |
| Arnett Marylou W | Director | filed 2010 - 2011 |
| Morra Bruce S | Director · Chief Executive Officer | filed 2007 - 2010 |
| Caudill Randall L W | Director | filed 2006 - 2009 |
| Wilds Daniel O | Director · President and CEO | filed 2006 - 2008 |
| Weaver Gregory L | Director | filed 2007 - 2008 |
| Fassihi Reza | Director | filed 2006 - 2008 |
| Sorell Michael | Director | filed 2006 - 2006 |
| Mueller Hans | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Levy Richard M | Chief Financial Officer | filed 2007 - 2012 |
| Mitchel Alan M | Sr. VP - Chief Legal Officer | filed 2006 - 2009 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.